Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.
Adriana Maria KakehasiSebastião Cezar RadominskiMarcos Daniel BaravalleFedra Consuelo Irazoque PalazuelosConrado Garcia-GarciaMaysa Silva ArrudaMarco CuriJohn LiuMeihua QiaoPatricia Velez-SanchezJuan Ignacio VargasPublished in: Clinical rheumatology (2023)
SELECT-EARLY, NCT02706873; SELECT-NEXT, NCT02675426; SELECT-COMPARE, NCT02629159; SELECT-MONOTHERAPY, NCT02706951; SELECT-BEYOND, NCT02706847; SELECT-CHOICE, NCT03086343.